Filing Details

Accession Number:
0001493152-19-019367
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-17 16:30:28
Reporting Period:
2019-12-16
Accepted Time:
2019-12-17 16:30:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1076682 Polarityte Inc. PTE Biological Products, (No Disgnostic Substances) (2836) 061529524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1455767 M Rainer Erdtmann 995 East Arques Avenue
Sunnyvale CA 94085
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-16 31,846 $2.47 30,000 No 4 S Indirect By Zeigeist Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Zeigeist Inc.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Direct
Footnotes
  1. Mr. Erdtmann owns and controls Zeigeist LLC. Zeigeist is a limited partner in Point Sur Investors Fund I, LP, a biotech investment fund,which sold its entire position in the common stock of the Issuer in accordance with Point Sur's investment policies. The number of shares sold isthe portion of shares sold by Point Sur that were owned indirectly through Zeigeist. Zeitgeist still owns directly 30,000 shares and Mr.Erdtmann still owns 20,000 shares directly.
  2. The reported price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.40 to $2.57, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and ExchangeCommission, upon request, full information regarding the number of shares sold at each separate price that was included in the calculation oftRheem warekigs:hted average price.